Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D03PKJ
|
||||
Former ID |
DIB008647
|
||||
Drug Name |
MK-6186
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Human immunodeficiency virus infection [ICD9: 279.3; ICD10:B20-B26] | Phase 1 | [523090] | ||
Company |
Merck & Co Inc
|
||||
Structure |
Download2D MOL |
||||
Formula |
C21H12Cl2N6O
|
||||
Canonical SMILES |
Clc1cc(Oc2c(Cl)ccc3c2cnn3Cc4n[nH]c5ncccc45)cc(c1)C#N
|
||||
InChI |
1S/C21H12Cl2N6O/c22-13-6-12(9-24)7-14(8-13)30-20-16-10-26-29(19(16)4-3-17(20)23)11-18-15-2-1-5-25-21(15)28-27-18/h1-8,10H,11H2,(H,25,27,28)
|
||||
InChIKey |
FZBAOOQVQXATRL-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | HIV reverse transcriptase | Target Info | Inhibitor | [531832] | |
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.